[1]
K. H. Pangalila, S. P. Tarigan, V. H. Arla, and W. Irawati, “Use of the GnRH Antagonist Elagolix for Endometriosis in Relation to Hypoestrogenic Effect in Women”, JBT, vol. 22, no. 2, pp. 541–548, May 2022.